NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/18/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization160,883 mln
Float1,239 mln
Earnings Date07/30/2026
EPS
7.35
Strong
P / E
17.64
Moderately valued
Piotroski F-Score
9
/ 9
Exceptional
Beneish M-Score
-2.48
Borderline
1-Year Forecast
158
Attractive
Relative Strength
31
/ 100
Underperforming
Business Description
Gilead Sciences is an American drug company founded in 1987 and based in Foster City, California, that researches, develops, and sells treatments for serious diseases with few or no existing options. Its products cover a wide range of conditions, including HIV, hepatitis B and C, COVID-19, dangerous fungal infections, and certain cancers. The company works alongside a number of partner organizations around the world to discover and bring new therapies to patients.
